Search clinical trials for: trilaciclib
Total 28 results
-
Henan Cancer HospitalJiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruitingNon-small Cell Lung CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
Taixing People's HospitalRecruiting
-
Sun Yat-sen UniversityNot yet recruitingCervical Cancer | Breast Cancer | Non-Small Cell Lung Cancer | Endometrial Cancer | Head And Neck Squamous Cell CarcinomasChina
-
The First Affiliated Hospital of Xinxiang Medical...Not yet recruiting
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.RecruitingMetastatic Triple-Negative Breast CancerUnited States
-
wang shusenRecruiting
-
Fudan UniversityNot yet recruitingAdvanced Non-Small Cell Lung Cancer
-
Sichuan UniversityShanxi Provincial Cancer Hospital; Mianyang Central Hospital; Chengdu First people... and other collaboratorsNot yet recruitingAdvanced Squamous Non-Small-Cell Lung Cancer
-
G1 Therapeutics, Inc.RecruitingExtensive-stage Small-cell Lung CancerSpain, Greece, Turkey, Poland, Georgia, Austria, Belgium, Bulgaria, Germany, Hungary
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
UNC Lineberger Comprehensive Cancer CenterG1 Therapeutics, Inc.Recruiting
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
G1 Therapeutics, Inc.TerminatedBladder Cancer | Urothelial Carcinoma | Chemotherapy-induced Neutropenia | Myelosuppression Adult | Metastatic Bladder CancerHungary, Spain, United States, France, Georgia
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Jiangsu Simcere Pharmaceutical Co., Ltd.G1 Therapeutics, Inc.Completed
-
Jiangsu Simcere Pharmaceutical Co., Ltd.G1 Therapeutics, Inc.Completed
-
G1 Therapeutics, Inc.TerminatedNSCLC | Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States
-
G1 Therapeutics, Inc.TerminatedColorectal Cancer Metastatic | Chemotherapeutic Toxicity | Myelosuppression-AdultChina, Spain, United States, Hungary, United Kingdom, Poland, Ukraine, Italy
-
G1 Therapeutics, Inc.TerminatedSmall Cell Lung CancerUnited States, Croatia, Belgium, Slovakia, Bosnia and Herzegovina, North Macedonia, Serbia, Slovenia
-
G1 Therapeutics, Inc.Roche-GenentechTerminatedSmall Cell Lung CancerUnited States, Spain, France, Bulgaria, Ukraine, Estonia, Latvia
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
G1 Therapeutics, Inc.Bionical EmasApproved for marketingSmall Cell Lung Cancer | Chemotherapeutic Toxicity | Myelosuppression Adult
-
G1 Therapeutics, Inc.CompletedSmall Cell Lung CancerSpain, United States, Georgia, France, Moldova, Republic of, Hungary, Poland